A growing body of literature underscores the interplay between the JNK signaling pathway and ROS regulation in cancer, neurodegenerative diseases, cardiovascular diseases, diabetes, and metabolic disorders [50,51,52,53,54]. This evidence concerns the gene MAPK8 and Other metabolic disease.